Does TORIPALIMAB Cause White blood cell count decreased? 144 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of White blood cell count decreased have been filed in association with TORIPALIMAB (LOQTORZI). This represents 10.7% of all adverse event reports for TORIPALIMAB.
144
Reports of White blood cell count decreased with TORIPALIMAB
10.7%
of all TORIPALIMAB reports
0
Deaths
74
Hospitalizations
How Dangerous Is White blood cell count decreased From TORIPALIMAB?
Of the 144 reports, 74 (51.4%) required hospitalization, and 16 (11.1%) were considered life-threatening.
Is White blood cell count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TORIPALIMAB. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does TORIPALIMAB Cause?
Myelosuppression (590)
Off label use (276)
Anaemia (67)
Hypothyroidism (67)
Neutrophil count decreased (67)
Nausea (60)
Rash (59)
Vomiting (58)
Platelet count decreased (53)
Diarrhoea (50)
What Other Drugs Cause White blood cell count decreased?
PALBOCICLIB (11,273)
LENALIDOMIDE (9,996)
FINGOLIMOD (3,597)
CLOZAPINE (3,454)
POMALIDOMIDE (3,328)
CYCLOPHOSPHAMIDE (2,868)
RITUXIMAB (2,268)
METHOTREXATE (2,107)
RIBAVIRIN (1,970)
VENETOCLAX (1,913)
Which TORIPALIMAB Alternatives Have Lower White blood cell count decreased Risk?
TORIPALIMAB vs TORSEMIDE
TORIPALIMAB vs TOVIAZ
TORIPALIMAB vs TOVORAFENIB
TORIPALIMAB vs TOZINAMERAN
TORIPALIMAB vs TRABECTEDIN